Evidence map›Paper›PMID 34622009›Full record

ArticleJGH open : an open access journal of gastroenterology and hepatology2021

Post-treatment serum Wisteria floribunda agglutinin-positive mac-2-binding protein level is a useful predictor of hepatocellular carcinoma development after hepatitis C virus eradication.

Shunsuke Sato, Hironori Tsuzura, Yuji Kita, Yuji Ikeda, Daishi Kabemura, Sho Sato, Nozomi Amano, Noboru Yatagai, Ayato Murata, Yuji Shimada and 1 more

Open access · goldAbstract read
In one paragraph

Article in JGH open : an open access journal of gastroenterology and hepatology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
0.2field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it, 2 citations in OpenAlex.

  1. Pooled it
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Shunsuke SatoDepartment of Gastroenterology and Hepatology Juntendo University Shizuoka Hospital Shizuoka Japan.ORCID https://orcid.org/0000-0002-7480-7283
Hironori TsuzuraDepartment of Gastroenterology and Hepatology Juntendo University Shizuoka Hospital Shizuoka Japan.
Yuji KitaDepartment of Gastroenterology and Hepatology Juntendo University Shizuoka Hospital Shizuoka Japan.
Yuji IkedaDepartment of Gastroenterology and Hepatology Juntendo University Shizuoka Hospital Shizuoka Japan.
Daishi KabemuraDepartment of Gastroenterology and Hepatology Juntendo University Shizuoka Hospital Shizuoka Japan.
Sho SatoDepartment of Gastroenterology and Hepatology Juntendo University Shizuoka Hospital Shizuoka Japan.
Nozomi AmanoDepartment of Gastroenterology and Hepatology Juntendo University Shizuoka Hospital Shizuoka Japan.
Noboru YatagaiDepartment of Gastroenterology and Hepatology Juntendo University Shizuoka Hospital Shizuoka Japan.
Ayato MurataDepartment of Gastroenterology and Hepatology Juntendo University Shizuoka Hospital Shizuoka Japan.
Yuji ShimadaDepartment of Gastroenterology and Hepatology Juntendo University Shizuoka Hospital Shizuoka Japan.
Takuya GendaDepartment of Gastroenterology and Hepatology Juntendo University Shizuoka Hospital Shizuoka Japan.
Juntendo University Shizuoka Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimsRecent advances of direct-acting antiviral drugs for hepatitis C virus (HCV) have dramatically improved the sustained virologic response (SVR) rate, but hepatocellular carcinoma (HCC) development rarely occurs even in patients who achieve an SVR. Wisteria floribunda agglutinin-positive mac-2-binding protein (WFA METHODS AND

resultsWe examined the association between WFA

conclusionsThe assessment of liver fibrosis using the WFA

Indexed as

direct‐acting antiviral drughepatitis C virushepatocellular carcinomainterferon‐based therapyinterferon‐free therapysustained virological responseWisteria floribunda agglutinin‐positive mac‐2‐binding protein

Identifiers

PMID34622009
PMCPMC8485411
OpenAlexW3200014240

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.